Transforming global food system could unlock trillions in economic gains

The Food System Economics Commission’s study reveals transforming global food systems could yield economic gains of up to $10 trillion annually, with implementation costs being a fraction of global GDP.

Kura’s stock jumps on PhIb readout; FDA lifts hold on INmune Bio program; Nanobiotix’s $20M milestone

Plus, news about Iterum Therapeutics, Astria Therapeutics, Aqemia, Akebia Therapeutics, Tourmaline Bio and Vera Therapeutics: Kura Oncology’s positive PhIb readout: The company is testing its

January 31, 2024

2seventy bio completes $40m haemophilia A program deal with Novo Nordisk – Pharmaceutical Technology

Some 2seventy bio team members that have been working on the haemophilia A program will now be joining Novo Nordisk. Image Credit: Andrey_Popov/Shutterstock. US-based 2seventy

June 27, 2024

Fezolinetant Benefits Women Not Suited for Hormone Therapy

PHILADELPHIA — Fezolinetant (Veozah) improved menopause-related vasomotor symptoms in women unsuited or unwilling to take hormone therapy, according to a pooled analysis of two phase

September 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.